A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders

被引：0
|
作者：
Takuo Juji
Marc Hertz
Kazuhiro Aoki
Daisuke Horie
Keiichi Ohya
Anand Gautam
Søren Mouritsen
Hiromi Oda
Kozo Nakamura
Sakae Tanaka
机构：
[1] Department of Orthopaedic Surgery,
[2] Faculty of Medicine,undefined
[3] The University of Tokyo,undefined
[4] 7-3-1 Hongo,undefined
[5] Bunkyo-ku,undefined
[6] Tokyo 113-0033,undefined
[7] Japan,undefined
[8] Section of Pharmacology,undefined
[9] Department of Hard Tissue Engineering,undefined
[10] Graduate School,undefined
[11] Tokyo Medical and Dental University,undefined
[12] Tokyo,undefined
[13] Japan,undefined
[14] Pharmexa A/S,undefined
[15] Hørsholm,undefined
[16] Denmark,undefined
来源：
Journal of Bone and Mineral Metabolism | 2002年 / 20卷
关键词：
Key words RANKL; osteoclast; vaccine; bone destruction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：266 / 268
页数：2
相关论文
共 50 条
  • [21] An integrated model for evaluation and simulation of therapeutic responses to bone-related therapies
    Peterson, M. C.
    Riggs, M. M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S468 - S468
  • [22] Bone-related disorders of the jaw: A clinico-radiological diagnostic algorithm
    Abdel Razek, Ahmed Abdel Khalek
    NEURORADIOLOGY JOURNAL, 2021, 34 (04): : 289 - 299
  • [23] Triptolide Prevents Bone Destruction in the Collagen-Induced Arthritis Model of Rheumatoid Arthritis by Targeting RANKL/RANK/OPG Signal Pathway
    Liu, Chunfang
    Zhang, Yanqiong
    Kong, Xiangying
    Zhu, Liuluan
    Pang, Jian
    Xu, Ying
    Chen, Weiheng
    Zhan, Hongsheng
    Lu, Aiping
    Lin, Na
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [24] Targeting Mitophagy as a Potential Therapeutic Approach for Age-Related Bone Diseases
    Zhang, Kehan
    Li, Qilin
    Zhang, Yuxiao
    Nuerlan, Gaoshaer
    Li, Yuanyuan
    Mao, Jing
    Gong, Shiqiang
    ADVANCED THERAPEUTICS, 2024, 7 (07)
  • [25] The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders
    Yamawaki, Kengo
    Kondo, Yuichiro
    Okada, Tsutomu
    Oshima, Takeshi
    Kakitani, Makoto
    Tomizuka, Kazuma
    SCIENTIFIC REPORTS, 2016, 6
  • [26] The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders
    Kengo Yamawaki
    Yuichiro Kondo
    Tsutomu Okada
    Takeshi Oshima
    Makoto Kakitani
    Kazuma Tomizuka
    Scientific Reports, 6
  • [27] Uncoupling bone formation and bone resorption: A novel therapeutic approach
    Rizzoli, R
    BONE, 2005, 36 : S477 - S477
  • [28] Stat3 Signaling Pathway: A Future Therapeutic Target for Bone-Related Diseases
    Li, Jiadong
    Yin, Zhifeng
    Huang, Biaotong
    Xu, Ke
    Su, Jiacan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [29] Targeting Osteoclasts with zoledronic acid prevents bone destruction in collagen induced arthritis.
    Sims, NA
    Green, JR
    Martin, J
    Gillespie, MT
    Romas, E
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S553 - S553
  • [30] Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis
    Sims, NA
    Green, JR
    Glatt, M
    Schlict, S
    Martin, TJ
    Gillespie, MT
    Romas, E
    ARTHRITIS AND RHEUMATISM, 2004, 50 (07): : 2338 - 2346
12345